您当前位置: 首页 > 国际期刊-ACTA PHARMACEUTICA期刊投稿发表详细信息
ACTA PHARMACEUTICA

ACTA PHARMACEUTICA Q3

  • 期刊收录:
  • SCIE
  • Scopus
  • DOAJ
基本信息
  • 期刊ISSN:

    1330-0075

  • 期刊简拼:

    ACTA PHARMACEUT

  • 年发文章数:

    45

  • E-ISSN:

    1846-9558

  • Gold OA文章占比

    98.44%

  • 研究文章占比:

    91.11%

  • 是否OA:

    Yes

  • Jcr分区:

    Q3

  • 中科院分区:

    4区

出版信息
  • 出版商:

    Sciendo, a De Gruyter company

  • 涉及研究方向:

    PHARMACOLOGY & PHARMACY-

  • 出版国家:

    CROATIA

  • 出版语言:

    English

  • 出版周期:

    Quarterly

  • 出版年份:

    1951

  • 2023-2024最新影响因子:2.1
  • 自引率:0.00%
  • 五年影响因子:2.4
  • JCI期刊引文指标:0.75
  • h-index:49
  • CiteScore:5.20

期刊简介

Acta Pharmaceutica (AP) is an international, scientific, multidisciplinary journal, devoted to the pharmaceutical and allied sciences, which contains articles predominantly on core biomedical and health subjects. The aim of AP is to increase the impact of pharmaceutical research in academia, industry and laboratories. With a strong emphasis on quality and originality, AP publishes reports from the discovery of a drug up to clinical practice, in the form of preliminary and short communications, original research papers and reviews. Book reviews are published also.

AP is a quarterly, single-blind peer-reviewed journal in biomedicine with fully open access and “early bird” platform. All articles are submitted to scrutinized evaluation and fair judgement. AP above all puts scientific honesty and integrity.


To reach the highest standards in publication ethics all the parties (authors, editors, reviewers) are required to behave responsibly and ethically. This implies submittance by authors on an exclusive basis, of only their own and new data; novelty and originality are prioritized. Also, secure handling of confidential data by reviewers and editors is a must.

AP is indexed in numerous world top international bibliographic bases, like Clarivate Analytics´s Web of Science® Core Collection (SCI-Expanded, JCR/Science Edition, etc.), EMBASE/Excerpta Medica, MEDLINE/PubMed, Scopus/SCImago, and others. According to SCImago JR it is a Q2 journal (pharmaceutical sciences) with a steadily increasing Clarivate JIF value reaching 2.8 in 2022.


Topics covered are:
• drug design

• molecular modelling/docking studies

• pharmaceutical chemistry/medicinal chemistry

• drug metabolism

• analytics of drugs

• pharmaceutical technology/formulation studies/nanosystems/cosmetology

• pharmaceutical biotechnology

• pharmaceutics/biopharmacy (including pharmacokinetics) and pharmacodynamics

• drug delivery/disposition and stability

• pharmacognosy and phytopharmacy

• pharmacology (clinical and animal)

• toxicology

• clinical pharmacy

• pharmacovigilance

• pharmaceutical and clinical biochemistry

• pharmaceutical biology with genetics/pharmacogenomics/cell biology

• pharmacoepidemiology/pharmacoeconomics/social pharmacy

• physical pharmacy

• radiopharmaceuticals

• medicine (including diagnostics and therapy)

• peptide and protein chemistry/protein design

《ACTA PHARMACEUTICA》期刊已被查看:
期刊简写:ACTA PHARMACEUT

此期刊被最新的JCR期刊SCIE收录

期刊信息

  • 通讯地址
  • HRVATSKO FARMACEUTSKO DRUSTOV (HFD)-CROATION PHARMACEUTICAL SOC, MASARYKOVA 2, ZAGREB, CROATIA, 10000
  • 中国科学院《国际期刊预警名单(试行)》名单
  • 2024年02月发布的2024版:不在预警名单中
    2023年01月发布的2023版:不在预警名单中
    2021年12月发布的2021版:不在预警名单中
    2020年12月发布的2020版:不在预警名单中
    此期刊被最新的JCR期刊SCIE收录
  • 审稿速度
  • 收录数据库
  • 是否oa
  • 研究方向
  • >12周,或约稿
  • SCIE,Scopus,DOAJ
  • Yes
  • PHARMACOLOGY & PHARMACY-

分区信息

中科院分区
  • 大类学科
  • 分区
  • 小类学科
  • Top期刊
  • 综述期刊
  • 医学
  • 4区
  • PHARMACOLOGY & PHARMACY
    药学
WOS分区等级:3区
  • 版本
  • 按学科
  • 分区
  • 影响因子
  • WOS期刊SCI分(2023-2024年最新版)
  • PHARMACOLOGY & PHARMACY
  • Q3
  • 2.1
IF值(影响因子)趋势图
年发文量趋势图
自引率趋势图
中科院分区

常见问题